Second Malignant Neoplasms Following Treatment for Childhood Cancer: A Population‐Based Registry Study

SMN risk remains significant for childhood cancer survivors, particularly for CNS and solid tumour cases, highlighting the need for tailored surveillance and further research on the strategies to mitigate long-term adverse outcomes.